Tél. : 0650740869

Our Team


Gilles is the Founder and CEO of DIVINCELL SAS. He was Director of Research at the National Center for Scientific Research (CNRS), Head of the Chemistry Biology and Nanotechnology for Health Team in Montpellier-France up 2016.


Gilles has over 25 years of experience in the field of nanotechnology and the vectorization of therapeutic molecules. He is one of the pioneers of the “non-covalent cell penetrating peptide-based strategy” for therapeutic delivery and the Inventor of “the peptide nanocage strategy” for targeted drug delivery for the treatment / diagnosis of many diseases. He is the author of more than 200 scientific publications and 20 granted patents.


Gilles has been an associate researcher at the Max Planck Institute for Medical Research in Heidelberg-Germany and at the SCRIPPS Research Institute, San Diego-USA. He holds a PhD in "Biochemistry-Biophysics" from the University of Lyon, France.

Dr NEIL DESAI, Scientific and Clinical Advisor

Neil is the Founder of Aadi Bioscience, Inc and Aadigen LLC. He was former SVP, Global R&D, Abraxis Bioscience; VP, Strategic Platforms, Celgene Corp; Inventor of the nab® technology, Abraxane® and ABI-009. He successfully led the Abraxane team through all development stages.


Neil has over 25 years of experience in novel therapeutic delivery systems with over 100 issued patents, over 40 peer-reviewed publications and book chapters, and over 200 presentations at scientific meetings. He is an active participant in FDA and EU Nanotechnology initiatives and a member of the Steering Committee for the National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer.


Neil holds board and advisory positions in various start-ups. He holds a M.S and Ph.D. in Chemical Engineering from the University of Texas at Austin, USA, and a B.S. in Chemical Engineering from the University Institute of Chemical Technology in Mumbai, India.

R&D team :

A Multidisciplinary team with a strong expertise covering all aspects, from fundamental research to therapeutic development.


Dr ELODIE CZUBA : PhD in chemistry/biology. R&D Manager of the Nanomedecine&Cellular Therapy Program

AUDREY GRUNENBERGER : University’s degree level in cell biology and biochemistry. Advanced Research Technician.

VERONICA GUZMAN :  Master’s degree in cell biology. PhD student under joint supervision DIVINCELL/IAB-INSERM Grenoble-FRANCE .

E. Czuba
V. Guzman
A. Grunenberger